Vanguard Capital Management
WST icon

Vanguard Capital Management’s West Pharmaceutical WST Stock Holding History

Vanguard Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.71B Sell
4,605,822
-7,312
-0.2% -$2.58M 0.04% 358
2026
Q2 		$1.66B Sell
4,613,134
-70,152
-1% -$21.4M 0.04% 378
2026
Q1 		$1.17B Buy
+4,683,286
New +$1.17B 0.03% 435

Other funds holding WST

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $54.9B AUM 27.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Vanguard Capital Management's WST Position: Q3 2026 in Review

Vanguard Capital Management reduced its West Pharmaceutical (WST) stake by 0.16% in Q3 2026, selling an estimated $2.58M and leaving 4,605,822 shares worth $1.71B. The position accounts for 0.04% of the portfolio, ranked #358.

Vanguard Capital Management first reported a position in WST in Q1 2026 and has held it in 3 quarters since. 716 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Vanguard Capital Management held 4,605,822 shares of West Pharmaceutical worth $1.71B as of Q3 2026.
  • Vanguard Capital Management sold 7,312 West Pharmaceutical shares in Q3 2026, an estimated $2.58M.
  • West Pharmaceutical made up 0.04% of Vanguard Capital Management's portfolio in Q3 2026, its #358 holding.
  • Vanguard Capital Management first reported a position in West Pharmaceutical in Q1 2026 and has held it in 3 quarters since.
  • 716 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.